Results 181 to 190 of about 365,877 (337)

Fortgeschrittenes NSCLC [PDF]

Wiener klinisches Magazin, 2016
openaire   +1 more source

GPR54 regulates non-small cell lung cancer development via dopa decarboxylase. [PDF]

Signal Transduct Target Ther
Hwang HH, Lee SY, Lee C, Lee JY, Ko SG, Cho SG.   +5 more
europepmc   +1 more source

Molecular crosstalk via exosomes in lung cancer progression

Interdisciplinary Medicine, EarlyView.
“Molecular and theranostics roles of exosomes in Lung Cancer.” Abstract Exosomes play a critical role in lung cancer metastasis, facilitating tumor progression through intercellular communication between cancer cells and the tumor microenvironment. These nanosized extracellular vesicles carry bioactive molecules such as proteins, nucleic acids, and ...
Rajib Dhar, Vinoth Kumarasamy, Brian G. Oliver, Vetriselvan Subramaniyan   +3 more
wiley   +1 more source

Effect of Perioperative Factors on Short-Term Outcomes in Patients with Non-Small Cell Lung Cancer Over 60 Years of Age

International Journal of General Medicine
Wenzhi Zhu,1,* Jiaonan Yang,1,* Xiaoyi Wang,2 Xinqiang Ji,2 Hongyu Tan1 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Anesthesiology, Peking University Cancer Hospital & Institute ...
Zhu W, Yang J, Wang X, Ji X, Tan H
doaj  

Supplementary Figure S4 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC [PDF]

Giulia Mazzaschi, Cristina Marrocchio, Lucas Moron Dalla Tor, Ludovica Leo, Maurizio Balbi, Gianluca Milanese, Ganiyat Adenike Ralitsa Adebanjo, Bruno Lorusso, Gregorio Monica, Monica Pluchino, Roberta Minari, Simona D’Agnelli, Elisa Cardinale, Fabiana Perrone, Paola Bordi, Alessandro Leonetti, Roberta Eufrasia Ledda, Mario Silva, Sebastiano Buti, Giovanni Roti, Stefano Bettati, Federico Quaini, Marcello Tiseo, Nicola Sverzellati   +23 more
openalex   +1 more source

Data from The Impact of <i>EGFR</i> T790M Mutations and <i>BIM</i> mRNA Expression on Outcome in Patients with <i>EGFR</i>-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial

, 2023
Carlota Costa, Miguel Angel Molina, Ana Drozdowskyj, Ana Giménez‐Capitán, Jordi Bertran-Alamillo, Niki Karachaliou, Radj Gervais, Bartomeu Massutí, Wei Jia, Teresa Morán, Margarita Majem, Enriqueta Felip, Enric Carcereny, Rosario García‐Campelo, Santiago Viteri, Miquel Tarón, Mayumi Ono, Petros Giannikopoulos, Trever G. Bivona, Rafael Rosell   +19 more
openalex   +1 more source

Gut microbiome‐derived metabolites show promise in cancer research and therapy

Interdisciplinary Medicine, EarlyView.
The metabolites produced by the gut microbiome, which are subject to regulation by multiple factors, play a pivotal role in the progression of various types of cancer. These metabolites not only function as potential biomarkers for the early detection and monitoring of tumor development, but also actively participate in cancer therapeutic processes ...
Kangjie Yang, Yifan Wang, Daolin Tang, Peilong Li, Lutao Du   +4 more
wiley   +1 more source

Figure S7 from The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials [PDF]

Benjamin Solomon, Daniel S.W. Tan, Gilberto de Castro, Manuel Cobo, Marina Chiara Garassino, Jun Zhang, Bruce E. Johnson, Jay M. Lee, Pilar Garrido, A. R. BUTLER, Marc R. Pelletier, Alexander Savchenko, Lexiang Ji, Jan C. Brase, Rafael Caparica, David Demanse, Jincheng Wu, Claudia Bossen, Tony Mok   +18 more
openalex   +1 more source

Data from Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

, 2023
Kai Zhang, Xiaohua Hong, Zhengbo Song, Yu Xu, Chengcheng Li, Guoqiang Wang, Yuzi Zhang, Xiaochen Zhao, Zhengyi Zhao, Jing Zhao, Mengli Huang, Depei Huang, Chuang Qi, Chan Gao, Shangli Cai, Feifei Gu, Yue Hu, Chunwei Xu, Wenxian Wang, Zhenkun Lou, Yong Zhang, Li Liu   +21 more
openalex   +1 more source

Optimising hypoxia PET imaging and its applications in guiding targeted radiation therapy for non‐small cell lung cancer: a scoping review

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 106-118, March 2025.
This review article reports that quantification of hypoxic volumes using PET in the pre‐radiation therapy setting is of prognostic value and indicative of treatment response in non‐small cell lung cancer. Abstract Introduction Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related death. Definitive treatment includes chemotherapy and
Carol Marks, Michelle Leech
wiley   +1 more source